Sign Up to like & get
recommendations!
0
Published in 2025 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.70085
Abstract: To assess whether exposure to an extended‐release (ER) oxycodone with abuse deterrent properties (ADF) reduced tampering of oxycodone in a real‐world, postmarket setting to address the thinking behind Category 4 labeling by the FDA.
read more here.
Keywords:
oxycodone;
deterrent properties;
abuse deterrent;
extended release ... See more keywords